UK 1997 [20] |
3.3 / week / 100,000 catchment area population ~5 people per week |
64% (nurses) |
1:1 |
Diazepam |
Most frequent |
27 (10–80) |
|
1 hypotention |
|
|
|
|
Haloperidol |
(exact data not presented) |
22 (10–60) |
26% |
1 cardiorespiratory arrest (60 mg haloperidol + 80 mg DZ) |
|
|
|
|
Chlorpromazine |
|
162 (50–400) |
|
1 tachycardia, 1 hypotention |
|
|
|
|
Droperidol |
|
14 (10–20) |
|
|
|
|
|
|
Paraldehyde |
|
|
|
1 respiratory distress |
|
|
|
|
Amytal |
|
|
|
|
|
|
|
|
Lorazepam |
|
|
|
|
|
|
|
|
Nitrazepam |
Least frequent |
|
|
|
France 1999 [18] |
5.6 / 1000 contacts |
86% (nurses) |
0:80 |
Loxapine |
80% |
200 mg |
|
2 with acute dystonia |
|
|
|
|
Droperidol |
5% |
|
|
|
|
|
|
|
Chlorazepate |
5% |
|
|
|
|
|
|
|
Cyamemazine |
< 2% |
|
6% |
Mostly people with substance abuse |
|
|
|
|
Diazepam |
|
|
|
|
|
|
|
|
Sultopride |
|
|
|
|
|
|
|
|
Meprobamate |
|
|
|
|
Brazil 2000 [13] |
2.1 / week / 100,000 catchment area population ~74 people per week |
Majority (restraints and nurses) |
0:74 |
Haloperidol + promethazine |
61% |
5 (2.5–10) + 50 (25–100) |
0% |
|
|
|
|
|
Haloperidol + Promethazine + Diazepam |
15% |
5 (2.5–10) + 50 (25–100) + 10 |
|
|
|
|
|
|
Diazepam |
9% |
10 |
|
|
|
|
|
|
Haloperidol + Promethazine + Chlorpromazine |
7% |
5 + 50 + 25 |
|
|
|
|
|
|
Chlorpromazine + Diazepam + Promethazine |
1% |
25 + 10 |
|
|
|
|
|
|
Chlorpromazine + Promethanzine |
1% |
25 + 50 |
|
|
|
|
|
|
Chlorpromazine |
1% |
25 |
|
|
|
|
|
|
Diazepam + Promethazine |
1% |
10 + 5 |
|
|
|
|
|
|
Haloperidol + Diazepam |
1% |
5 + 10 |
|
|
|
|
|
|
Promethazine |
1% |
50 |
|
|